What it said it expected, against what it reported
3 targets with a reported result
Above the range
2
above the last range given
Within the range
0
of 3 range targets
Below the range
1
below the last range given
The numbers GILD said it expected, in its earnings releases, next to what it then reported for the same period.
Target by target
Each target, with the sentence it came from
| Target | What the company said | Reported | Result |
|---|---|---|---|
| Operating income Fiscal 2026 |
Given $11.40B to $11.90B release 2026-02-10
|
– | Not reported yet |
The company's words(in millions, except percentages and per share Provided amounts) February 10, 2026 Projected product gross margin GAAP to non-GAAP reconciliation: Projected ope … GAAP projected operating income $11,400 - $11,900 release 2026-02-10 | |||
| Operating income (company-defined) Fiscal 2026 |
Given $13.80B to $14.30B release 2026-02-10
|
– | No standard number |
The company's words(in millions, except percentages and per share Provided amounts) February 10, 2026 Projected product gross margin GAAP to non-GAAP reconciliation: Projected ope … Non-GAAP projected operating income $13,800 - $14,300 release 2026-02-10 | |||
| Diluted EPS Fiscal 2026 |
Given $6.75 to $7.15 release 2026-02-10
|
– | Not reported yet |
The company's words(in millions, except percentages and per share Provided amounts) February 10, 2026 Projected product gross margin GAAP to non-GAAP reconciliation: Projected ope … GAAP projected diluted EPS $6.75 - $7.15 release 2026-02-10 | |||
| Diluted EPS (company-defined) Fiscal 2026 |
Given $8.45 to $8.85 release 2026-02-10
|
– | No standard number |
The company's words(in millions, except percentages and per share Provided amounts) February 10, 2026 Projected product gross margin GAAP to non-GAAP reconciliation: Projected ope … Non-GAAP projected diluted EPS $8.45 - $8.85 release 2026-02-10 | |||
| Operating income Fiscal 2025 (ended 2025-12-31) |
Given $10.20B to $10.70B release 2025-02-11
|
$10.02B 10-K filed 2026-02-24 |
Below the range |
The company's words(in millions, except percentages and per share Provided amounts) February 11, 2025 Projected product gross margin GAAP to non-GAAP reconciliation: Projected ope … GAAP projected operating income $10,200 - $10,700 release 2025-02-11 | |||
| Operating income (company-defined) Fiscal 2025 (ended 2025-12-31) |
Given $12.70B to $13.20B release 2025-02-11
|
– | No standard number |
The company's words(in millions, except percentages and per share Provided amounts) February 11, 2025 Projected product gross margin GAAP to non-GAAP reconciliation: Projected ope … Non-GAAP projected operating income $12,700 - $13,200 release 2025-02-11 | |||
| Diluted EPS Fiscal 2025 (ended 2025-12-31) |
Given $5.95 to $6.35 release 2025-02-11
|
$6.78 10-K filed 2026-02-24 |
Above the range |
The company's words(in millions, except percentages and per share Provided amounts) February 11, 2025 Projected product gross margin GAAP to non-GAAP reconciliation: Projected ope … GAAP projected diluted EPS $5.95 - $6.35 release 2025-02-11 | |||
| Diluted EPS (company-defined) Fiscal 2025 (ended 2025-12-31) |
Given $7.70 to $8.10 release 2025-02-11
|
– | No standard number |
The company's words(in millions, except percentages and per share Provided amounts) February 11, 2025 Projected product gross margin GAAP to non-GAAP reconciliation: Projected ope … Non-GAAP projected diluted EPS $7.70 - $8.10 release 2025-02-11 | |||
| Operating income (company-defined) Fiscal 2024 (ended 2024-12-31) |
Given $11.20B to $11.70B release 2024-02-06
|
– | No standard number |
The company's words(in millions, except percentages and per share Provided amounts) February 6, 2024 Projected product gross margin GAAP to non-GAAP reconciliation: Projected oper … Non-GAAP projected operating income $11,200 - $11,700 release 2024-02-06 | |||
| Diluted EPS (company-defined) Fiscal 2024 (ended 2024-12-31) |
Given $6.85 to $7.25 release 2024-02-06
|
– | No standard number |
The company's wordsGilead is providing full-year 2024 guidance below: … Non-GAAP diluted EPS between $6.85 and $7.25. release 2024-02-06 | |||
| Revenue Fiscal 2024 (ended 2024-12-31) |
Given $27.10B to $27.50B release 2024-02-06
|
$28.75B 10-K filed 2025-02-28 |
Above the range |
The company's wordsGilead is providing full-year 2024 guidance below: … Total product sales between $27.1 billion and $27.5 billion. release 2024-02-06 | |||
| Revenue (company-defined) Fiscal 2024 (ended 2024-12-31) |
Given $25.80B to $26.20B release 2024-02-06
|
– | No standard number |
The company's wordsGilead is providing full-year 2024 guidance below: … Total product sales, excluding Veklury, between $25.8 billion and $26.2 billion. release 2024-02-06 | |||
2 targets far from the company's reported total, so not compared (usually a target for one product, segment or definition)
- Operating income, Fiscal 2024 (ended 2024-12-31): said $8.70B to $9.20B, reported $1.66B. The company's words
- Diluted EPS, Fiscal 2024 (ended 2024-12-31): said $5.15 to $5.55, reported $0.38. The company's words
Targets are read from the sentences of the EX-99 exhibits of 8-K item 2.02 filings (13 releases since 2023-11-07), without AI; in outlook tables only the first column is read. The result compares the reported number with the last range given before the period was reported. Results come from SEC's XBRL company facts, as first reported. A company's target can use its own definition (META's capital expenditures include finance lease payments, for example), so read the quote.